For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Undaunted, Bloomfield boxes on
Wednesday 28 August 2019, 02:00 AM

Director-general of health Ashley Bloomfield reckons his ministry is leading more effectively on many fronts
Ashley Bloomfield is one year into his job as director-general of health. Virginia McMillan returns to the Ministry of Health to quiz him on changes and progress made
I feel we are in a really good position to be able to support the Government in response to the primary care Treaty of Waitangi claim
A year ago,
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.